Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
Hanus
H
H
Dept. Psychiat., CS-500 36 Hradec Králové, CSFR.
Tůtma
I
I
Zapletálek
M
M
Fusek
J
J
Hrdina
V
V
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000523:psychology; D005059:Euphoria / Q000187:drug effects; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications; D013619:Tacrine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D013619:Tacrine; C016222:7-methoxytacrine